. doi: 10.1016/j.virs.2026.08.001
Citation: Biao Li, Bao Dong, Yuehong Chen, Jing Li, Xiaoping Kang, Yuchang Li, Sen Zhang, Jiaqi Xiong, Zhengwei Zhang, Jun Hu, Shuimeng Song, Shenghai Huang, Ye Feng, Tao Jiang. A modular APEX biosensor enables sensitive and visualized monitoring of viral protease activity .VIROLOGICA SINICA, 2026, 41(4) : 972-987.  http://dx.doi.org/10.1016/j.virs.2026.08.001

一种模块化APEX生物传感器可实现病毒蛋白酶活性的灵敏可视化检测

  • 病毒蛋白酶是广谱抗病毒药物研发的核心靶点,亟需一套可在贴近生理状态的细胞环境中精准评估抑制剂活性的筛选平台。传统检测方法(如荧光蛋白检测、荧光共振能量转移 FRET 技术)存在明显缺陷:易受化合物非特异性构象干扰,且无法真实反映胞内抑制效果。为此,本研究构建了两种基于抗坏血酸过氧化物酶(APEX)的模块化生物传感器 TS3AR 与 C3SIR。其检测机制如下:蛋白酶特异性切割底物识别序列后,可促使拆分型 APEX 片段重新组装、恢复酶催化活性,并通过级联放大反应产生荧光信号。以冠状病毒主蛋白酶(Mpro)为模型开展验证实验,结果显示 TS3AR 传感器可将酶活检测信噪比提升至 1500 倍;C3SIR 传感器则能有效规避传统方法中由构象干扰引发的假阳性,精准筛选出恩司特韦、PF-00835231、奈玛特韦等高效 Mpro 抑制剂。同时,仅替换蛋白酶识别序列,该模块化传感器便可灵活检测多种冠状病毒(新冠病毒、中东呼吸综合征病毒等)的主蛋白酶(Mpro),同时适用于肠道病毒71型、EB病毒、甲肝病毒等其他病毒蛋白酶的活性检测与药物筛选评价。本研究由此为新发及现有病毒的广谱抗病毒药物快速研发,提供了一种稳定、特异性强的胞内药物筛选工具。

A modular APEX biosensor enables sensitive and visualized monitoring of viral protease activity

  • Viral proteases are key targets for the development of broad-spectrum antiviral drugs development. However, screening platform capable of accurately assessing inhibitor activity within physiologically relevant cellular environments remain urgently needed. Traditional methods, such as fluorescent protein assays and Förster resonance energy transfer (FRET), suffer from significant limitations, including susceptibility to non-specific conformational interference by test compounds and an inability to faithfully reflect intracellular inhibitory effects. To address these challenges, we constructed two modular biosensors (TS3AR and C3SIR) based on engineered ascorbate peroxidase (APEX). Their detection mechanism relies on specific cleavage of the substrate recognition sequence by the target protease, which triggers the reassembly of split APEX fragments, restores enzymatic activity, and generates fluorescent signals generated via cascade amplification reaction. Validation using the coronavirus main protease (Mpro) as a model showed that the TS3AR sensor achieved the signal-to-noise ratio up to 1500-fold for enzyme activity detection, while the C3SIR sensor effectively avoided the false positives caused by conformational interference seen in traditional methods and accurately identified high-potency Mpro inhibitors, including enstrelvir, PF-00835231, and nirmatrelvir. Moreover, by replacing the protease recognition sequence, these modular biosensors can be flexibly adapted for activity analysis and drug evaluation of Mpro from various coronaviruses (e.g., SARS-CoV-2, MERS-CoV) as well as other viral proteases (e.g., enterovirus 71, Epstein-Barr virus and hepatitis A virus). Overall, this platform provides a reliable, highly specific intracellular screening tool to accelerate the development of broad-spectrum therapeutics against both emerging and existing viral threats.

  • 加载中
    1. Battison, A.S., Balsbaugh, J.L.,Borniger, J.C., 2025. APEX2 and TurboID define unique subcellular proteomes. Sci Rep, 15, 43547.

    2. Becker, J.T., Auerbach, A.A.,Harris, R.S., 2023. APEX3 - An Optimized Tool for Rapid and Unbiased Proximity Labeling. Journal of Molecular Biology, 435(13):168145.

    3. Berlec, A., Skrlec, K., Kocjan, J., Olenic, M.,Strukelj, B., 2018. Single plasmid systems for inducible dual protein expression and for CRISPR-Cas9/CRISPRi gene regulation in lactic acid bacterium Lactococcus lactis. Sci Rep, 8, 1009.

    4. Costanzo, L.F.D., 2025. Viral proteases: Structural basis of function, evolution, and drug design. Enzymes, 58, 19-57.

    5. Dong, B., Chen, Y., Wang, X., Li, J., Zhang, S., Kang, X., Li, Y., Li, B., Liao, L., Zhang, Z., Xiong, J., Shao, L., Huang, S., Feng, Y.,Jiang, T., 2025. Development of a highly sensitive luciferase assay for intracellular evaluation of coronavirus Mpro activity. Frontiers in Microbiology, 16:1560251.

    6. Eid, M., Barayeu, U., Sulkova, K., Aranda-Vallejo, C.,Dick, T.P., 2024. Using the heme peroxidase APEX2 to probe intracellular H(2)O(2) flux and diffusion. Nat Commun, 15, 1239.

    7. Elmsaouri, S., Markmiller, S.,Yeo, G.W., 2022. APEX Proximity Labeling of Stress Granule Proteins. Methods Mol Biol, 2428, 381-399.

    8. Geng, C.A., Chen, F.Y., Zheng, J.B., Liao, P., Li, T.Z., Zhang, X.M., Chen, X.,Chen, J.J., 2023. Rubiginosin B selectively inhibits Treg cell differentiation and enhances anti-tumor immune responses by targeting calcineurin-NFAT signaling pathway. Phytomedicine, 116, 154898.

    9. Guo, Z., Zhong, X., Lin, L., Wu, S., Wang, T., Chen, Y., Zhai, X., Wang, Y., Wu, H., Tong, L., Han, Y., Pan, B., Peng, Y., Si, X., Zhang, F., Zhao, W.,Zhong, Z., 2014. A 3C(pro)-dependent bioluminescence imaging assay for in vivo evaluation of anti-enterovirus 71 agents. Antiviral Res, 101, 82-92.

    10. Han, Y., Branon, T.C., Martell, J.D., Boassa, D., Shechner, D., Ellisman, M.H.,Ting, A., 2019. Directed Evolution of Split APEX2 Peroxidase. ACS Chemical Biology, 14, 619-635.

    11. Hayashi, T., Hirano, J., Murakami, K., Fujii, Y., Kobayashi, S., Tanikawa, T., Kitamura, M.,Someya, Y., 2025. Identification of FDA-Approved Drugs That Inhibit SARS-CoV-2 and Human Norovirus Replication. Biol Pharm Bull, 48, 994-1000.

    12. Hung, V., Udeshi, N.D., Lam, S.S., Loh, K.H., Cox, K.J., Pedram, K., Carr, S.A.,Ting, A.Y., 2016. Spatially resolved proteomic mapping in living cells with the engineered peroxidase APEX2. Nat Protoc, 11, 456-475.

    13. Kaewsapsak, P., Shechner, D.M., Mallard, W., Rinn, J.L.,Ting, A.Y., 2017. Live-cell mapping of organelle-associated RNAs via proximity biotinylation combined with protein-RNA crosslinking. Elife, 66:e29224.

    14. Kalocsay, M., 2019. APEX Peroxidase-Catalyzed Proximity Labeling and Multiplexed Quantitative Proteomics. Methods Mol Biol, 2008, 41-55.

    15. Kapust, R.B., Tozser, J., Copeland, T.D.,Waugh, D.S., 2002. The P1' specificity of tobacco etch virus protease. Biochem Biophys Res Commun, 294, 949-955.

    16. Kim, Y., Lovell, S., Tiew, K.C., Mandadapu, S.R., Alliston, K.R., Battaile, K.P., Groutas, W.C.,Chang, K.O., 2012. Broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, noroviruses, and coronaviruses. J Virol, 86, 11754-11762.

    17. Kleeman, B., Olsson, A., Newkold, T., Kofron, M., Delay, M., Hildeman, D.,Grimes, H.L., 2018. A guide to choosing fluorescent protein combinations for flow cytometric analysis based on spectral overlap. Cytometry A, 93, 556-562.

    18. Lee, I.G., Lee, J., Hong, S.H.,Seo, Y.J., 2023. Apigenin's Therapeutic Potential Against Viral Infection. Front Biosci (Landmark Ed), 28, 237.

    19. Leonard, R.A., Rao, V.N., Bartlett, A., Froggatt, H.M., Luftig, M.A., Heaton, B.E.,Heaton, N.S., 2023. A low-background, fluorescent assay to evaluate inhibitors of diverse viral proteases. J Virol, 97, e0059723.

    20. Liu, X., Zhang, Q., Li, M., Qin, S., Zhao, Z., Lin, B., Ding, Y., Xiang, Y.,Li, C., 2023. Horseradish peroxidase (HRP) and glucose oxidase (GOX) based dual-enzyme system: Sustainable release of H(2)O(2) and its effect on the desirable ping pong bibi degradation mechanism. Environ Res, 229, 115979.

    21. Lobingier, B.T., Huttenhain, R., Eichel, K., Miller, K.B., Ting, A.Y., Von Zastrow, M.,Krogan, N.J., 2017. An Approach to Spatiotemporally Resolve Protein Interaction Networks in Living Cells. Cell, 169, 350-360.e312.

    22. Ma, C., Tan, H., Choza, J., Wang, Y.,Wang, J., 2022. Validation and invalidation of SARS-CoV-2 main protease inhibitors using the Flip-GFP and Protease-Glo luciferase assays. Acta Pharmaceutica Sinica B, 12, 1636-1651.

    23. Muramatsu, T., Takemoto, C., Kim, Y.-T., Wang, H., Nishii, W., Terada, T., Shirouzu, M.,Yokoyama, S., 2016. SARS-CoV 3CL protease cleaves its C-terminal autoprocessing site by novel subsite cooperativity. Proceedings of the National Academy of Sciences, 113, 12997-13002.

    24. Nicholls, S.B., Chu, J., Abbruzzese, G., Tremblay, K.D.,Hardy, J.A., 2011. Mechanism of a genetically encoded dark-to-bright reporter for caspase activity. J Biol Chem, 286, 24977-24986.

    25. Ovechkina, V.S., Zakian, S.M., Medvedev, S.P.,Valetdinova, K.R., 2021. Genetically Encoded Fluorescent Biosensors for Biomedical Applications. Biomedicines, 9(11):1528.

    26. Pena-Francesch, M., Vanoaica, L.D., Zhu, G.F., Stumpe, M., Sankar, D.S., Nowag, H., Valencia-Camargo, A.D., Hammerschmidt, W., Dengjel, J., Ligeon, L.A.,Munz, C., 2023. The autophagy machinery interacts with EBV capsids during viral envelope release. Proc Natl Acad Sci U S A, 120, e2211281120.

    27. Ran, Y., Chen, Z., Sacramento, C.Q., Fan, L., Cui, Q., Rong, L.,Du, R., 2025. Scutellaria barbata D. Don extracts alleviate SARS-CoV-2 induced acute lung injury by inhibiting virus replication and bi-directional immune modulation. Virol Sin, 40, 430-438.

    28. Scott, D., Dikici, E., Ensor, M.,Daunert, S., 2011. Bioluminescence and its impact on bioanalysis. Annu Rev Anal Chem (Palo Alto Calif), 4, 297-319.

    29. Senapati, S., Kaushik, A., Rajan, Singh, A., Gupta, I., Virkar, R., Kulkarni, S.S., Arankalle, V.,Singh, J.P., 2025. Rapid, On-Site SARS-CoV-2 Variant Detection and Differentiation Using GLAD-Pristine Silver Nanorod Arrays and Machine Learning-Enhanced SERS. ACS Omega, 10, 44978-44988.

    30. Shen, H., Liu, S., Shang, L., Liu, Y., Sha, Y., Lei, D., Zhang, Y., Jin, C., Wu, S., Zhang, M., Wen, H., Jia, C.,Wang, J., 2025. Discovery of Small-Molecule Inhibitors Against Norovirus 3CL(pro) Using Structure-Based Virtual Screening and FlipGFP Assay. Viruses, 17(11):1277.

    31. Sun, L.Y., Chen, C., Su, J., Li, J.Q., Jiang, Z., Gao, H., Chigan, J.Z., Ding, H.H., Zhai, L.,Yang, K.W., 2021. Ebsulfur and Ebselen as highly potent scaffolds for the development of potential SARS-CoV-2 antivirals. Bioorg Chem, 112, 104889.

    32. Takashima, J.A., Woroniecka, H.A.,Charest, P.G., 2024. APEX2-Mediated Proximity Protein Labeling in Dictyostelium. Methods Mol Biol, 2814, 119-131.

    33. Trompet, D., Melis, S., Chagin, A.S.,Maes, C., 2024. Skeletal stem and progenitor cells in bone development and repair. J Bone Miner Res, 39, 633-654.

    34. Vuong, W., Khan, M.B., Fischer, C., Arutyunova, E., Lamer, T., Shields, J., Saffran, H.A., Mckay, R.T., Van Belkum, M.J., Joyce, M.A., Young, H.S., Tyrrell, D.L., Vederas, J.C.,Lemieux, M.J., 2020. Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication. Nature Communications, 11(1):4282.

    35. Woo, J., Park, H., Na, Y., Kim, S., Choi, W.I., Lee, J.H., Seo, H.,Sung, D., 2020. Novel fluorescein polymer-based nanoparticles: facile and controllable one-pot synthesis, assembly, and immobilization of biomolecules for application in a highly sensitive biosensor. RSC Adv, 10, 2998-3004.

    36. Ye, J., Zhang, R., Zhou, J., Xu, T., Liu, X.,Chen, Y., 2025. Systematic Reevaluation of Repurposed Drugs Against the Main Protease of SARS-CoV-2 via Combined Experiments. J Med Virol, 97, e70229.

    37. Zhang, Q., Schepis, A., Huang, H., Yang, J., Ma, W., Torra, J., Zhang, S.-Q., Yang, L., Wu, H., Nonell, S., Dong, Z., Kornberg, T.B., Coughlin, S.R.,Shu, X., 2019. Designing a Green Fluorogenic Protease Reporter by Flipping a Beta Strand of GFP for Imaging Apoptosis in Animals. Journal of the American Chemical Society, 141, 4526-4530.

    38. Zhang, R., Yan, H., Zhou, J., Yan, G., Liu, X., Shang, C.,Chen, Y., 2024. Improved fluorescence-based assay for rapid screening and evaluation of SARS-CoV-2 main protease inhibitors. J Med Virol, 96, e29498.

    39. Zhou, G., Wan, W.W.,Wang, W., 2022. Modular Peroxidase-Based Reporters for Detecting Protease Activity and Protein Interactions with Temporal Gating. Journal of the American Chemical Society, 144, 22933-22940.

    40. Zhou, J., Zhang, R., Yan, H., Liu, X., Shang, C.,Chen, Y., 2025. Evaluation of natural products from virtual screenings as SARS-CoV-2 main protease inhibitors using combinational experiments. Nat Prod Res, 39, 1493-1496.

  • 加载中
  • 10.1016j.virs.2026.08.001-ESM.docx

Figures(1)

Article Metrics

Article views(367) PDF downloads(0) Cited by(0)

Related
Proportional views
    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    A modular APEX biosensor enables sensitive and visualized monitoring of viral protease activity

      Corresponding author: Shenghai Huang, shhuang@ahmu.edu.cn
      Corresponding author: Ye Feng, fengye621@126.com
      Corresponding author: Tao Jiang, jiang_tao@126.com
    • a. School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China;
    • b. State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Beijing 100071, China;
    • c. School of Public Health, Mudanjiang Medical University, Mudanjiang 157011, China

    Abstract: Viral proteases are key targets for the development of broad-spectrum antiviral drugs development. However, screening platform capable of accurately assessing inhibitor activity within physiologically relevant cellular environments remain urgently needed. Traditional methods, such as fluorescent protein assays and Förster resonance energy transfer (FRET), suffer from significant limitations, including susceptibility to non-specific conformational interference by test compounds and an inability to faithfully reflect intracellular inhibitory effects. To address these challenges, we constructed two modular biosensors (TS3AR and C3SIR) based on engineered ascorbate peroxidase (APEX). Their detection mechanism relies on specific cleavage of the substrate recognition sequence by the target protease, which triggers the reassembly of split APEX fragments, restores enzymatic activity, and generates fluorescent signals generated via cascade amplification reaction. Validation using the coronavirus main protease (Mpro) as a model showed that the TS3AR sensor achieved the signal-to-noise ratio up to 1500-fold for enzyme activity detection, while the C3SIR sensor effectively avoided the false positives caused by conformational interference seen in traditional methods and accurately identified high-potency Mpro inhibitors, including enstrelvir, PF-00835231, and nirmatrelvir. Moreover, by replacing the protease recognition sequence, these modular biosensors can be flexibly adapted for activity analysis and drug evaluation of Mpro from various coronaviruses (e.g., SARS-CoV-2, MERS-CoV) as well as other viral proteases (e.g., enterovirus 71, Epstein-Barr virus and hepatitis A virus). Overall, this platform provides a reliable, highly specific intracellular screening tool to accelerate the development of broad-spectrum therapeutics against both emerging and existing viral threats.

    Figure (1)  Reference (40) Relative (20)

    目录

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return